Rhelion Life Sciences Overview
- Year Founded
-
1982
- Status
-
Public
- Stock Symbol
-
RHEL
- Investments
-
18
- Share Price
-
$0.02
- (As of Friday Closing)
Rhelion Life Sciences General Information
Description
Rhelion Life Sciences Corp is a pharmaceutical research and development company focused on the discovery and development of natural psychedelic medicines for psychiatric and neurological conditions. Its products include Botanical Psilocybin, Botanical Coca Extract, and Botanical Ibogaine. The Company operates in the Netherlands, Canada, and the United States, with maximum revenue from the Netherlands.
Contact Information
Website
www.redlight.coCorporate Office
- 1 Adelaide Street East
- Suite 801
- Toronto, Ontario M5C 2V9
- Canada
Corporate Office
- 1 Adelaide Street East
- Suite 801
- Toronto, Ontario M5C 2V9
- Canada
Rhelion Life Sciences Stock Performance
As of 13-Nov-2026, Rhelion Life Sciences’s stock price is $0.02. Its current market cap is $10.8M with 614M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $0.01 - $0.04 | $10.8M | 614M | 223K |
Rhelion Life Sciences Financials Summary
As of 30-Jun-2026, Rhelion Life Sciences has a trailing 12-month revenue of $2.23M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 6,702 | 1,648 | 1,100 | 7,439 |
| Revenue | 2,228 | 3,035 | 3,548 | 3,522 |
| EBITDA | (5,352) | (5,075) | (2,757) | (5,272) |
| Net Income | (5,021) | (4,415) | (2,901) | (5,652) |
| Total Assets | 15,383 | 10,459 | 14,829 | 17,824 |
| Total Debt | 1,017 | 1,019 | 1,526 | 1,270 |
Rhelion Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rhelion Life Sciences Patents
Rhelion Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022232933-A1 | Personalized microdosing kits and protocols based on biometric and movement data correlated with natural product qualities | Inactive | 04-May-2021 | ||
| US-11806162-B2 | Methods and systems for the use of 3d human movement data | Active | 28-Jul-2020 | ||
| US-20230172536-A1 | Methods and systems for the use of 3d human movement data | Active | 28-Jul-2020 | A61B5/4848 |
Rhelion Life Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Rhelion Life Sciences Investments & Acquisitions (18)
Rhelion Life Sciences’s most recent deal was a Merger/Acquisition with Filament Health for . The deal was made on 29-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Filament Health | 29-Apr-2026 | Merger/Acquisition | Drug Discovery | ||
| Happy Caps Mushroom Farm | 02-Apr-2024 | Secondary Transaction - Private | Horticulture | ||
| SmartShop Utrecht | 26-Jul-2022 | Merger/Acquisition | Specialty Retail | ||
| Red Light Holland (100 Acres of Farmland in Peterborough, Ontario) | 20-Jun-2022 | Corporate Asset Purchase | Buildings and Property | ||
| MiniChamp | 10-Apr-2022 | Merger/Acquisition | Food Products |
Rhelion Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Packaged Foods
Subindustry
Rank
Percentile
Rhelion Life Sciences Exits (4)
Rhelion Life Sciences’s most recent exit was on 26-Jul-2022 from SmartShop Utrecht. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SmartShop Utrecht | 26-Jul-2022 | Completed |
|
||
| Mera Life Sciences | 24-Aug-2021 | Completed |
|
||
| Patricia Mining | 15-Sep-2005 | Completed |
|
||
| African Aura Resources | PIPE | Completed |
Rhelion Life Sciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Filament Health | Vancouver, Canada | 2020 | |
| MiniChamp | Horst, Netherlands | 2006 |
Rhelion Life Sciences FAQs
-
When was Rhelion Life Sciences founded?
Rhelion Life Sciences was founded in 1982.
-
Where is Rhelion Life Sciences headquartered?
Rhelion Life Sciences is headquartered in Toronto, Canada.
-
What industry is Rhelion Life Sciences in?
Rhelion Life Sciences’s primary industry is Food Products.
-
Is Rhelion Life Sciences a private or public company?
Rhelion Life Sciences is a Public company.
-
What is Rhelion Life Sciences’s stock symbol?
The ticker symbol for Rhelion Life Sciences is RHEL.
-
What is the current stock price of Rhelion Life Sciences?
As of 13-Nov-2026 the stock price of Rhelion Life Sciences is $0.02.
-
What is the current market cap of Rhelion Life Sciences?
The current market capitalization of Rhelion Life Sciences is $10.8M.
-
What is Rhelion Life Sciences’s current revenue?
The trailing twelve month revenue for Rhelion Life Sciences is $2.23M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process